The distinction observed between the VPS35-mutated samples and the other tested samples with point mutations might be simply attributable to the fact that the D620N mutation in VPS35 disrupts both the distribution of endosomes33 and mitochondrial functions18, while the other PD genetic point mutations mainly affect the latter. This evidence concerns the gene VPS35 and Parkinson disease.